1. 1) Japanese Association for Infectious Diseases/Japanese Society of Chemotherapy, “The JAID/JSC Guide to Clinical Management of Infectious Diseases 2019,” Life Science Publishing Co., Ltd., Tokyo, 2019, pp. 3-271.
2. 2) Japanese Society of Chemotherapy/Japan Society for Surgical Infection. “Jutsugo Kansen Yobo Kokinyaku Tekisei Shiyo no tame no Jissen Guideline.”: 〈http://www.gekakansen.jp/file/antimicrobial-guideline.pdf〉, cited 2 August, 2022.
3. 3) Nagashima T., Shoji T., Nakamura I., Endo T., Yonezawa Y., Takeno T., Komatsuzaki Y., Yamazaki H., Kito K., Tanaka H., Yamane R., Murai K., Ikeda M, Saito Y., Toyama K., Hanaoka H., Ukai T., Hokao N., Uenaka K., Oral. Therap. Pharmacol., 35, 16-26 (2016).
4. 4) Yoshida K., Kodama Y., Isobe H., Yamada E., Nishikawa A., Takagi R., Jpn. J. Environ. Infect., 33, 207-212 (2018).
5. 5) Kodama Y., Yoshida K., Nagai T., Nishikawa A., Goto S., Aoki M., Uchiyama M., Takagi R., Jpn. J. Environ. Infect., 35, 48-57 (2020).